Giuseppe Maria Milano
Biographic Data
| ID | 8260137 |
|---|---|
| NAME | Giuseppe Maria Milano |
| GIVEN NAMES | Giuseppe Maria |
| FAMILY NAME | Milano |
| SIGNATURE | MILANO G M |
| AFFILIATIONS | Istituti di Ricovero e Cura a Carattere Scientifico |
| ORCID | 0000-0002-0250-6043 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
A New Proximal Femur Reconstruction Technique after Bone Tumor Resection in a Very Small Patient
For patients too young to be fitted with an expandable prosthesis, limb salvage surgery requires other strategies. The main problems are related to the impossibility of implanting an expandable prosthesis to the residual bone growth that is much too big in relation to the bone size, with the precocious implant loosening and/or the residual absence of bone growth, as well as the problem of limb length and shape difference. In this paper, we report…
Inflammatory Myofibroblastic Tumor of the Upper Airways Harboring a New TRAF3-ALK Fusion Transcript
Inflammatory myofibroblastic tumor (IMT) is a rare disease that mainly involves the lung and the abdomen with an intermediate clinical course but a recurrence rate between 15-30%. Radical surgery represents the gold standard of treatment, while chemotherapy and radiotherapy are considered for unresectable lesions. The identification of ALK translocations in IMT opened the option for the use of target therapies. Indeed, the ALK inhibitors have cha…
No prominent works on this page.
A New Proximal Femur Reconstruction Technique after Bone Tumor Resection in a Very Small Patient
For patients too young to be fitted with an expandable prosthesis, limb salvage surgery requires other strategies. The main problems are related to the impossibility of implanting an expandable prosthesis to the residual bone growth that is much too big in relation to the bone size, with the precocious implant loosening and/or the residual absence of bone growth, as well as the problem of limb length and shape difference. In this paper, we report…
Inflammatory Myofibroblastic Tumor of the Upper Airways Harboring a New TRAF3-ALK Fusion Transcript
Inflammatory myofibroblastic tumor (IMT) is a rare disease that mainly involves the lung and the abdomen with an intermediate clinical course but a recurrence rate between 15-30%. Radical surgery represents the gold standard of treatment, while chemotherapy and radiotherapy are considered for unresectable lesions. The identification of ALK translocations in IMT opened the option for the use of target therapies. Indeed, the ALK inhibitors have cha…
Medicine (2 works) · Cancer Research (1 work) · Chemotherapy (1 work) · Femur (1 work) · Fibula (1 work) · Humerus (1 work) · IgG4-Related and Inflammatory Diseases (1 work) · Implant (1 work) · Internal Medicine (1 work) · Lung (1 work)